Induced forms of α


Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
01 Aug 2021
Historique:
received: 17 05 2021
revised: 07 06 2021
accepted: 08 06 2021
pubmed: 15 6 2021
medline: 4 8 2021
entrez: 14 6 2021
Statut: ppublish

Résumé

Alpha

Identifiants

pubmed: 34126147
pii: S0141-8130(21)01264-2
doi: 10.1016/j.ijbiomac.2021.06.058
pii:
doi:

Substances chimiques

Factor Xa Inhibitors 0
Methylamines 0
Pregnancy-Associated alpha 2-Macroglobulins 0
Heparin 9005-49-6
methylamine BSF23SJ79E
Factor Xa EC 3.4.21.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

209-217

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Georges Jourdi (G)

Université de Paris, Innovative Therapies in Haemostasis, INSERM UMR_S1140, F-75006, Paris, France; AP-HP. Centre-Université de Paris, Hôpital Cochin, F-75014, Paris, France; Research Centre, Montreal Heart Institute, University of Montreal, Faculty of Pharmacy, Montreal, Canada. Electronic address: georges.jourdi@inserm.fr.

Johan Abdoul (J)

Université de Paris, Innovative Therapies in Haemostasis, INSERM UMR_S1140, F-75006, Paris, France.

Virginie Siguret (V)

Université de Paris, Innovative Therapies in Haemostasis, INSERM UMR_S1140, F-75006, Paris, France; AP-HP. Nord-Université de Paris, Hôpital Lariboisière, F-75010 Paris, France.

Xavier Decleves (X)

AP-HP. Centre-Université de Paris, Hôpital Cochin, F-75014, Paris, France; Université de Paris, Variabilité de réponse aux psychotropes, INSERM UMR_S1144, F-75006 Paris, France.

Elisa Frezza (E)

Laboratoire CiTCoM, Université de Paris, CNRS, F-75006 Paris, France.

Claire Pailleret (C)

Université de Paris, Innovative Therapies in Haemostasis, INSERM UMR_S1140, F-75006, Paris, France; Clinique du Mont Louis, F-75011 Paris, France.

Isabelle Gouin-Thibault (I)

Laboratoire d'hématologie, CHU Pontchaillou, Université de Rennes 1, CIC-Inserm1414, F-35000 Rennes, France.

Sophie Gandrille (S)

Université de Paris, Innovative Therapies in Haemostasis, INSERM UMR_S1140, F-75006, Paris, France; AP-HP. Centre-Université de Paris, Hôpital Européen Georges Pompidou, F-75015 Paris, France.

Nathalie Neveux (N)

AP-HP. Centre-Université de Paris, Hôpital Cochin, F-75014, Paris, France.

Charles Marc Samama (CM)

Université de Paris, Innovative Therapies in Haemostasis, INSERM UMR_S1140, F-75006, Paris, France; AP-HP. Centre-Université de Paris, Hôpital Cochin, F-75014, Paris, France.

Samuela Pasquali (S)

Laboratoire CiTCoM, Université de Paris, CNRS, F-75006 Paris, France.

Pascale Gaussem (P)

Université de Paris, Innovative Therapies in Haemostasis, INSERM UMR_S1140, F-75006, Paris, France; AP-HP. Centre-Université de Paris, Hôpital Européen Georges Pompidou, F-75015 Paris, France. Electronic address: pascale.gaussem@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH